⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16926354 | 1.00 | — | — | |
| SCHEMBL5747174 | 1.00 | — | — | |
| SCHEMBL5747179 | 1.00 | — | — | |
| SCHEMBL2896873 | 0.76 | — | — | |
| SCHEMBL5158354 | 0.74 | — | — | |
| Hydrochloric Acid SCHEMBL2902386 | 0.74 | — | — | |
| SCHEMBL16659921 | 0.74 | — | — | |
| SCHEMBL4480811 | 0.74 | — | — | |
| SCHEMBL12141649 | 0.74 | — | — | |
| SCHEMBL28286598 | 0.72 | GAA (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105899491-B | 1-pyridazine-/triazin-3-yl-piperazine (-oxazine)/pyridine/pyrrolidine derivatives and compositions thereof for inhibiting SHP2 activity | 诺华股份有限公司 | 2019-04-02 | — | — | CN | disclosed |
| CN-105899493-B | For inhibiting the active 1- of SHP2 (triazine -3- base/pyridazine -3- base)-piperazine (- piperazine) piperidine derivatives and combinations thereof | 诺华股份有限公司 | 2019-03-29 | — | — | CN | disclosed |
| EP-3094627-A1 | 1 -PYRIDAZIN-/TRIAZIN-3-YL-PIPER(-AZINE)/IDINE/PYROLIDINE DERIVATIVES AND AND COMPOSITIONS THEREOF FOR INHIBITING THE ACTIVITY OF SHP2 | Novartis AG (CH) | 2016-11-23 | — | — | EP | disclosed |
| EP-3094629-A1 | 1 -(TRIAZIN-3-YI_/PYRIDAZIN-3-YL)-PIPER(-AZINE)IDINE DERIVATIVES AND COMPOSITIONS THEREOF FOR INHIBITING THE ACTIVITY OF SHP2 | Novartis AG (CH) | 2016-11-23 | — | — | EP | disclosed |
| CN-105899493-A | 1 -(triazin-3-yi_/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions thereof for inhibiting the activity of SHP2 | 诺华股份有限公司 | 2016-08-24 | — | — | CN | disclosed |
| CN-105899491-A | 1-pyridazine-/triazin-3-yl-piperazine (-oxazine)/pyridine/pyrrolidine derivatives and compositions thereof for inhibiting SHP2 activity | 诺华股份有限公司 | 2016-08-24 | — | — | CN | disclosed |
| WO-2015107493-A1 | 1 -PYRIDAZIN-/TRIAZIN-3-YL-PIPER(-AZINE)/IDINE/PYROLIDINE DERIVATIVES AND AND COMPOSITIONS THEREOF FOR INHIBITING THE ACTIVITY OF SHP2 | NOVARTIS AG (CH) | 2015-07-23 | — | — | WO | disclosed |
| WO-2015107494-A1 | 1 -(TRIAZIN-3-YI_/PYRIDAZIN-3-YL)-PIPER(-AZINE)IDINE DERIVATIVES AND COMPOSITIONS THEREOF FOR INHIBITING THE ACTIVITY OF SHP2 | NOVARTIS AG (CH) | 2015-07-23 | — | — | WO | disclosed |
| EP-1578743-A4 | ANTIBACTERIAL AGENTS | GLAXO GROUP LTD (GB) | 2006-11-29 | — | — | EP | disclosed |
| US-20060041123-A1 | Antibacterial agents | GLAXO GROUP LIMITED (GB) | 2006-02-23 | — | — | US | disclosed |
| EP-1578743-A2 | ANTIBACTERIAL AGENTS | GLAXO GROUP LIMITED (GB) | 2005-09-28 | — | — | EP | disclosed |
| WO-2004058144-A2 | ANTIBACTERIAL AGENTS | GLAXO GROUP LIMITED (GB) | 2004-07-15 | — | — | WO | disclosed |